Statistics
The NeuroOne Medical Technologies stock price is currently $ 0.7451 with a total market cap valuation of $ 6.78M (9.11M shares outstanding). The NeuroOne Medical Technologies is trading on NASDAQ under the ticker sign NMTC. NeuroOne Medical Technologies price is up
Description
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.
Company Profile
- Full Name: NeuroOne Medical Technologies
- Sector: Healthcare
- Website: https://n1mtc.com
